
Opinion|Videos|December 15, 2023
Teaser: Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Bronchiectasis Hospitalizations Deadlier, Costlier Than Those for COPD, Asthma
2
Contributor: Engagement Is the Missing Link in Kidney Care—How Payers and Value-Based Partnerships Can Close the Gap
3
FDA Approves Selumetinib for Adults With Neurofibromatosis Type 1
4
FDA Approves Sevabertinib for Nonsquamous NSCLC
5














































